Viewing nowOmecsild Tablet 10mg (Olmesartan Medoxomil)
Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

MFDS item code 201900105 · Approved 2019.01.09 · Insurance code 654005250
Treatment of essential hypertension
Essential hypertension is a condition where blood pressure is persistently high, placing strain on the heart and blood vessels. This medication helps lower blood pressure and reduce the risk of cardiovascular disease. With consistent use and management, it aids in maintaining healthy blood pressure levels. Therefore, it is used for the treatment of essential hypertension.
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment, with the maximum effect occurring at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have decreased effective intravascular volume (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Elderly patients> No dose adjustment is required when this drug is administered to patients aged 65 years or older. No overall differences in efficacy or safety have been observed between elderly and younger patients; however, the possibility of a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this drug is not recommended.
<Children> The safety and efficacy in children have not been established.
This medication can cause serious harm or death to the fetus and newborn, especially during the second and third trimesters of pregnancy, so use should be discontinued immediately upon confirmation of pregnancy. This medication should not be used by individuals who are allergic to it, pregnant or breastfeeding women, patients undergoing kidney dialysis, individuals with severe liver impairment, or patients with bile duct obstruction. Patients with reduced blood volume or those taking high doses of diuretics may experience hypotension; therefore, they should carefully check their condition and begin treatment accordingly. Patients with impaired kidney function, kidney transplant recipients, patients with renovascular hypertension, and those at risk for hyperkalemia require careful monitoring and regular testing when taking this medication. Patients with aortic stenosis, mitral stenosis, obstruction, or hypertrophic cardiomyopathy should also use caution when taking this medication. Dizziness may occur during treatment; therefore, operation of hazardous machinery or driving should be avoided. Mild side effects such as dizziness, headache, dyspepsia, back pain, bronchitis, increased creatine phosphokinase, diarrhea, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, sinusitis, abdominal pain, dyspepsia, gastroenteritis, nausea, hypercholesterolemia, hyperlipidemia, hyperuricemia, arthralgia, arthritis, myalgia, rash, hair loss, pruritus, cough, epistaxis, and upper respiratory infections may occur. Rarely, angioedema or liver function abnormalities have been reported. Chronic diarrhea and weight loss associated with chronic malabsorption-like enteropathy may occur; if these symptoms develop, consult a doctor immediately. When taken with potassium-sparing diuretics or potassium supplements, blood potassium levels may increase, so caution is advised, and co-administration with lithium preparations is not recommended. Taking this medication simultaneously with non-steroidal anti-inflammatory drugs may worsen kidney function, hence hydration and renal function tests are required at the beginning of treatment. It is crucial to avoid using this medication during pregnancy to protect fetal health, and if breastfeeding, consider discontinuing the medication or stopping nursing due to potential adverse reactions in the infant. Safety in pediatric patients has not been established, and elderly patients may require dosage adjustment and caution due to increased drug concentration in the body. Overdose may result in hypotension, palpitations, bradycardia, etc., and appropriate treatment is needed based on the symptoms.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 degree and 25 degrees Celsius at room temperature.
White round film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowOlmesartan Medoxomil 10mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 40mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Olmesartan Medoxomil 10mg
Tablet · Prescription medication
Jongkeundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Olmesartan Medoxomil 20mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.